Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 17496
Country/Region: Côte d'Ivoire
Year: 2017
Main Partner: Population Services International
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USDOD
Total Funding: $1,252,323 Additional Pipeline Funding: $314,579

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $106,750
Care: TB/HIV (HVTB) $9,358
Care: Pediatric Care and Support (PDCS) $59,603
Laboratory Infrastructure (HLAB) $133,980
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $39,000
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $528,225
Sexual Prevention: Other Sexual Prevention (HVOP) $99,893
Treatment: Adult Treatment (HTXS) $222,347
Treatment: Pediatric Treatment (PDTX) $53,167
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 16,588
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 5
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 538
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 2
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 202
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 19
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 1,916
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 26
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 2,536
HTS_TST Service Delivery Point by Agg Age(Community) Mobile Testing: <15, Female, Negative 2018 265
HTS_TST Service Delivery Point by Agg Age(Community) Mobile Testing: <15, Male, Negative 2018 265
HTS_TST Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Negative 2018 3,765
HTS_TST Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Negative 2018 6,355
HTS_TST Sum of Test Result disaggregates 2018 694
HTS_TST_POS By Test Result: Positive 2018 694
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 22
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 22
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 101
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 78
HTS_TST_POS Service Delivery Point by Agg Age(Community) Mobile Testing: <15, Female, Positive 2018 14
HTS_TST_POS Service Delivery Point by Agg Age(Community) Mobile Testing: <15, Male, Positive 2018 14
HTS_TST_POS Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Positive 2018 197
HTS_TST_POS Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Positive 2018 242
PP_PREV Age/sex: 20-24 Female 2018 49
PP_PREV Age/sex: 20-24 Male 2018 4,847
PP_PREV Age/sex: 25-49 Female 2018 81
PP_PREV Age/sex: 25-49 Male 2018 8,077
PP_PREV Age/sex: 50+ Female 2018 33
PP_PREV Age/sex: 50+ Male 2018 3,231
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 16,318
PP_PREV Sum of Age/Sex disaggregates 2018 16,318
TX_CURR Aggregated Age/Sex: <15 Female 2018 18
TX_CURR Aggregated Age/Sex: <15 Male 2018 18
TX_CURR Aggregated Age/Sex: 15+ Female 2018 187
TX_CURR Aggregated Age/Sex: 15+ Male 2018 1,030
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 1,253
TX_CURR Sum of Aggregated Age/Sex <15 2018 36
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 1,217
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 1,253
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 11
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 11
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 69
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 366
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 457
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 457
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 145
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 7
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 1
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 6
TX_PVLS Numerator: Indication: Targeted 2018 7
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 2
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 1
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 12
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 130
TX_PVLS_den Denominator: Indication: Targeted 2018 145
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 8
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 7
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 73
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 426
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 514
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 669
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 11
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 10
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 104
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 544
Cross Cutting Budget Categories and Known Amounts Total: $152,650
Gender: Gender Equality $35,000
Changing harmful gender norms and promoting positive gender norms
Equity in HIV prevention, care, treatment and support
Increase gender-equitable access to income and productive resources, including education
Key Populations: Sex Workers $50,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Collection and use of strategic information on SWs and clients
Motor Vehicles: Purchased $48,900
Water $18,750